Lin28B was first cloned from and was shown to be overexpressed in human HCC cells and clinical samples 15, and it functions as an oncogene by promoting malignant transformation 16, 17, facilitating tumor‐associated inflammation 18, 19, reprogramming metabolism, acquiring immortality, and evading immune destruction 20. Here, LIN28B is linked to hepatocellular carcinoma.